Rapid, Bluetooth-Connected Test Diagnoses COVID-19 in 60 Seconds
Hememics Biotechnologies Inc. (Gaithersburg, MD, USA) is partnering with the Biomedical Advanced Research and Development Authority {(BARDA) Washington, DC, USA}, a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the US Department of Health and Human Services (HHS), on the development of a rapid, Bluetooth®-connected, easy-to-use test to diagnose COVID-19 in 60 seconds or less. More...18 Apr 2020
Moderna Awarded USD 483 Million by BARDA for Advancing mRNA Vaccine against Coronavirus
Moderna, Inc. (Cambridge, MA, USA) has been awarded USD 483 million by the Biomedical Advanced Research and Development Authority {(BARDA) Washington, DC, USA}, a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the US Department of Health and Human Services (HHS), to accelerate development of the company’s mRNA vaccine candidate (mRNA-1273) against the novel coronavirus (SARS-CoV-2). More...18 Apr 2020
Cornell Researchers Target Coronavirus Membrane Fusion Mechanism for Antiviral Development
A team of researchers from Cornell University (Ithaca, NY, USA) has proposed that blocking membrane fusion – a critical part of the mechanism by which coronaviruses spread – could offer a potential target for antiviral treatment for COVID-19. More...18 Apr 2020
DiaCarta’s QuantiVirus PCR Diagnostic Test Receives US FDA Emergency Use Authorization
DiaCarta Inc. (Richmond, CA, USA), a precision molecular diagnostic company, has secured Emergency Use Authorization from the US FDA for its proprietary QuantiVirus™ PCR diagnostic (Dx) test specifically detecting three different genes of SARS-CoV-2. More...17 Apr 2020
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
New
Monitor Cart
Tryten S5
New
Hospital Bed
Alphalite
In Other News
ECR 2020 to Go Ahead as Online Congress on July 15-19, 2020
Thermo Fisher and Ford Partner to Scale Production of Collection Kits for COVID-19 Tests
Blocking Key Enzyme in Human Cell Could Prevent COVID-19 from Multiplying
Fujifilm Begins US Phase II Clinical Trial of Avigan for COVID-19 Patients and Increases Production
Applied DNA Ships COVID-19 LinearDNA Vaccine Candidates to Takis Biotech for Preclinical Animal Testing
DiaSorin to Launch New LIAISON IgG Test for Detecting Immune Response to SARS-CoV-2
Eurofins Launches Range of ELISA Testing Kits for COVID-19 Antibody Detection
72nd AACC Annual Scientific Meeting & Clinical Lab Expo Rescheduled to December 13-17, 2020 Due to COVID-19
Gilead's Remdesivir Partial Trial Data Shows Success in Treating Severe COVID-19 Patients
AI-Based Chest X-Ray Diagnosis Technology Secures CE Mark Approval
Flipping COVID-19 Patients onto Their Stomachs Can Keep Them Alive in Intensive Care
New Rapid Testing Method That Detects Viral Antigens Can Diagnose COVID-19 at Early Stage
University of Pittsburgh School of Medicine’s COVID-19 Vaccine Candidate Shows Promise
B. Braun Infusion Pumps Receive FDA Emergency Use Authorization for Use with Nebulizers to Treat COVID-19
BD Announces Second FDA Emergency Use Authorization for New COVID-19 Molecular Diagnostic Test
Abbott’s Third COVID-19 Test Launched, Begins Shipping in US
Ortho's Total Antibody Test for COVID-19 Secures FDA Emergency Use Authorization
Moderna’s Positive Phase 1 Readouts of mRNA Vaccine Candidates Indicate Potential for Coronavirus Prevention
Celltrion Developing ‘Super Antibody’ Targeting Potential SARS-CoV-2 Mutations
Immunomic, EpiVax and PharmaJet Jointly Developing COVID-19 Vaccine
AstraZeneca Begins Global Clinical Trial of Calquence to Treat COVID-19 Infection
Sanofi and GSK Announce Unprecedented Vaccine Collaboration to Fight COVID-19
First Ever Multiplexed Serological SARS-CoV-2 Assay Released for Use in Surveillance Studies
